Friedrich Luft Received Novartis Award for his Research on Hypertension
Luft's group identified a specific gene region on chromosome 12 as a reason
David Ausserhofer / MDC
Luft's group identified a specific gene region on chromosome 12 in a family from Turkey in which half of all family members have severe hypertension resulting in stroke before the age of 50. All affected persons also have brachydactyly (short fingers), a not immediately obvious connection.
The group has not yet elucidated the precise cause for this syndrome. However, the finding that affected persons have a major defect in baroreflex buffering (detecting blood pressure and reacting to it) is a novel phenotype.
Professor Nihat Bilginturan from the University of Ankara, Ankara, Turkey, first described this syndrome in the international literature and is a co-investigator on the project. Luft's current MDC partners in this project are Norbert Hübner and Nikolaus Rajewsky.
Luft was also recognized for research done 30 years ago. The notion that the kidney is the final common pathway of blood pressure regulation, a concept termed "pressure natriuresis", stems from seminal research of Ewald Selkurt, Arthur Guyton, and others from the 1950's and later. However, relevance to normal humans had not been shown.
Luft and co-investigators, as well as co-subjects, performed balance studies in ranges of salt (NaCl) intake from 250 mg (knife tip) to more than 80 g (swallow the whole salt shaker and more). The idea was to study the effects of salt on blood pressure and more importantly, renal mechanisms of salt excretion. The findings defined the renal "pressure-natriuresis curve" for humans.
The studies also gave insight into the propensity to hypertension in salt-resistant and salt-sensitive forms. Finally, the studies indicated potassium as a factor in influencing the effects of salt.
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.